Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Diseases × Paclitaxel × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Pancreatic Intraductal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Thrombosis 1 Stage IA Uterine Sarcoma 1 Solid Tumors 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Organoid 1 Neoplasms, Germ Cell and Embryonal 1 NSCLC 1 Medulloblastoma 1 Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1 Infections 1 Hepatoblastoma 1

Interventions

Exercise 2 pyrotinib 1 palbociclib 1 Trastuzumab 1 Tomography, X-Ray Computed 1 Surveys and Questionnaires 1 Surgimend 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Fentanyl 1 Epirubicin 1 Educational Status 1 Docetaxel 1 Cyclophosphamide 1 Cryotherapy 1 Cholecalciferol 1 Carboplatin 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03756090 2018-12-07

PECP

Zhejiang Cancer Hospital

Phase NA Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡